RAP1A and myocardial infarction: This study demonstrated the potential of BYHWD to attenuate MI-induced platelet hyperreactivity, which is associated with platelet aggregation and adhesion, clot retraction, increased expression of p-selectin by regulating Rap1 signaling and reducing levels of inflammatory factors, directly providing references for BYHWD treatment in clinical practice.